OR WAIT null SECS
Moderna will double the space at its Moderna Technology Center in Norwood, MA, to transform it from a production and lab space into an industrial technology center.
Moderna announced on May 4, 2021 that it is doubling the space of its Moderna Technology Center in Norwood, MA, to transform it from a production and lab space into an industrial technology center.
The expansion will include increasing the facility’s production and lab space from 30,000 ft2 to 650,000 ft2 through renovations and the acquisition of an additional 240,000-ft2 space located on the same campus, Moderna said in a company press release. The expansion will also include a 50% increase in production of Moderna’s COVID-19 vaccine and an increase in the company’s technical development capacity and preclinical production capabilities.
“Our manufacturing facility has been core to our long-term strategy and has enabled us to provide the scale and flexibility to support the development of our mRNA [messenger RNA] medicines and vaccines, including our COVID-19 vaccine,” said Stéphane Bancel, CEO of Moderna, in the press release. “We believe that this investment and expansion at our technology center will allow us to continue to optimize our mRNA products as we explore new pharmaceutical delivery forms, such as prefilled syringes and lyophilized products. As we grow, we are committed to minimizing our environmental footprint.”